Article
Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component.
Cell proliferation - 1 Aug 1999
Greco C, Ameglio F, Alvino F, Mosiello A, Cianciulli A M, Venturo I, Del Monte G, Giampaolo M, Tong A W, Gandolfo G M
Abstract excerpt
As at present only a long-term follow-up can fully determine whether monoclonal gammapathies of undetermined significance (MGUS) will evolve into multiple myeloma (MM), this study attempted to identify other variables connected with the amount of monoclonal component (MC), generally considered as the most reliable marker of malignant evolution. Thirty-four MGUS subjects showing a high MC (> or = 15.0 g/l) but...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.